Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidex for Peri-Operative Tube Otorrhea
NCT00578773Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Nov 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of moxifloxacin + dexamethasone in acute otitis media (AOM) (3 arms), sponsored by Alcon Inc. Primary endpoint: Time to cessation of otorrhea. Started Nov 2007; status: completed.
02
Drugs
moxifloxacin + dexamethasone
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT00578773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578773.